Spot Trading’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$5.81M Buy
30,600
+8,200
+37% +$1.56M 0.1% 236
2017
Q2
$4.21M Buy
22,400
+18,600
+489% +$3.34M 0.08% 284
2017
Q1
$628K Sell
3,800
-1,500
-28% -$239K 0.02% 1080
2016
Q4
$762K Buy
5,300
+2,100
+66% +$281K 0.02% 1136
2016
Q3
$401K Sell
3,200
-10,800
-77% -$1.39M 0.01% 1651
2016
Q2
$1.84M Buy
14,000
+3,200
+30% +$438K 0.03% 746
2016
Q1
$1.5M Sell
10,800
-5,200
-33% -$695K 0.03% 863
2015
Q4
$2.23M Buy
16,000
+10,100
+171% +$1.39M 0.02% 940
2015
Q3
$826K Buy
5,900
+5,600
+1,867% +$842K 0.01% 1710
2015
Q2
$49K Sell
300
-1,300
-81% -$208K ﹤0.01% 3292
2015
Q1
$247K Buy
+1,600
New +$228K ﹤0.01% 2599
2014
Q4
Sell
-3,800
Closed -$455K 4113
2014
Q3
$455K Sell
3,800
-67,600
-95% -$7.75M ﹤0.01% 2620
2014
Q2
$7.68M Sell
71,400
-9,600
-12% -$989K 0.04% 699
2014
Q1
$8.06M Sell
81,000
-2,400
-3% -$217K 0.05% 570
2013
Q4
$7.71M Sell
83,400
-70,800
-46% -$6.29M 0.04% 589
2013
Q3
$12.9M Sell
154,200
-5,400
-3% -$463K 0.08% 275
2013
Q2
$13.1M Buy
+159,600
New +$11.9M 0.08% 253

Other funds holding ELV

Spot Trading's ELV Position: Q2 2017 in Review

Spot Trading sold out of Elevance Health (ELV) in Q2 2017, closing a stake of 634 shares — an estimated $114K sold.

Spot Trading first reported a position in ELV in Q2 2013 and held it in 10 quarters. The position peaked at $6.04M in Q3 2014. 851 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

  • Spot Trading reported no remaining Elevance Health position as of Q2 2017 after selling out during the quarter.
  • Spot Trading sold 634 Elevance Health shares in Q2 2017, an estimated $114K.
  • Spot Trading first reported a position in Elevance Health in Q2 2013 and held it in 10 quarters.
  • Spot Trading's Elevance Health position peaked at $6.04M in Q3 2014.
  • 851 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on Spot Trading's 13F filing for Q2 2017, filed 27 Jul 2017.